About the role
Company Overview: Pancreatic cancer and other hard-to-treat solid tumors are typically treated with systemic IV chemotherapy, which exposes the whole body to the drug rather than concentrating it at the tumor. RenovoRx (Nasdaq: RNXT) takes a targeted approach with its Trans-Arterial Micro-Perfusion (TAMP™) therapy platform, enabled by RenovoCath®, a patented, FDA-cleared dual-balloon drug-delivery catheter that isolates an arterial segment and delivers chemotherapy directly to the tumor. Renovo…
This is the opening of the ad. Read the full description on Adzuna.